000 01347 a2200361 4500
005 20250513140707.0
264 0 _c19980402
008 199804s 0 0 eng d
022 _a0028-4793
024 7 _a10.1056/NEJM199804023381412
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKudelka, A P
245 0 0 _aComplete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470.
_h[electronic resource]
260 _bThe New England journal of medicine
_cApr 1998
300 _a991-2 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAntibiotics, Antineoplastic
_xtherapeutic use
650 0 4 _aCarcinoma, Squamous Cell
_xdrug therapy
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aCyclohexanes
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aNeovascularization, Pathologic
_xdrug therapy
650 0 4 _aO-(Chloroacetylcarbamoyl)fumagillol
650 0 4 _aSesquiterpenes
_xtherapeutic use
650 0 4 _aUterine Cervical Neoplasms
_xdrug therapy
700 1 _aVerschraegen, C F
700 1 _aLoyer, E
773 0 _tThe New England journal of medicine
_gvol. 338
_gno. 14
_gp. 991-2
856 4 0 _uhttps://doi.org/10.1056/NEJM199804023381412
_zAvailable from publisher's website
999 _c9495243
_d9495243